Jasmeet Kaur, MD, FACP

Specialty: Medical Oncology
Department of Medicine - Gastrointestinal

 Request an Appointment
Locations

Cancers Treated:

Colon Colorectal Esophageal Gallbladder & Bile Duct Liver Neuroendocrine Tumors Pancreatic Stomach

Specializing In:

  • Neuroendocrine neoplasms, including well-differentiated and high-grade tumors
  • Biliary tract cancers, including cholangiocarcinoma and gallbladder cancer
  • Hepatocellular carcinoma (HCC) and primary liver cancers
  • Gastroesophageal cancers
  • Individualized, evidence-based systemic therapy selection
  • Geriatric oncology and care of older adults with gastrointestinal cancers
  • Integration of supportive care and symptom management into oncologic treatment
  • Multidisciplinary and patient-centered cancer care delivery

Research Interests:

  • Clinical and outcomes-based research to improve survival and quality of life in patients with gastrointestinal cancers
  • Neuroendocrine tumors and neuroendocrine neoplasms, including treatment patterns and outcomes
  • Biliary tract malignancies and real-world effectiveness of systemic therapies
  • Utilization, effectiveness and toxicity of immunotherapy in gastrointestinal cancers and solid cancers
  • Treatment-related toxicities and their impact on treatment adherence and outcomes
  • Nutritional status, cachexia and supportive care interventions in GI oncology
  • Influence of age, comorbidities and functional status on cancer treatment tolerance
  • Geriatric oncology approaches to optimize outcomes for older adults with GI malignancies
  • Real-world data analyses to inform personalized cancer care

Biography

I am an Assistant Professor of Gastrointestinal Medical Oncology at Roswell Park Comprehensive Cancer Center in Buffalo, New York.

I completed my Hematology and Oncology fellowship at Fox Chase Cancer Center, where I developed specialized training in gastrointestinal oncology and multidisciplinary cancer care. Prior to fellowship, I completed my Internal Medicine residency at Saint Joseph Mercy Oakland Hospital. Earlier in my career, I trained in Radiation Oncology in India, which has informed my collaborative, multimodality perspective on cancer treatment, symptom management and survivorship.

Positions

Roswell Park Comprehensive Cancer Center

  • Assistant Professor of Oncology
  • Department of Medicine - Gastrointestinal

Background

Education and Training

  • 2006-2011 - MBBS - Sri Guru Ramdas Institute of Health Sciences and Research/ Baba Farid University, Amritsar, India

Residency

  • 2019-2022 - Internal Medicine Residency, Trinity Health Hospital, Oakland/Wayne State University, Pontiac, MI
  • 2013-2016 - Radiation Oncology Residency, Guru Gobind Singh Medical College/Baba Farid University, Faridkot, India

Fellowship

  • 2022-20225 - Medical Oncology Fellowship, Fox Chase Cancer Center/Temple University Hospital, Philadelphia, PA

Board Certification

  • American Board of Internal Medicine- Medical Oncology
  • American Board of Internal Medicine- Hematology
  • American Board of Internal Medicine- Internal Medicine

Professional Memberships

  • ASCO
  • ASH
  • NANETS
  • AACR
  • ACP

Honors & Awards

  • Fellow of the American College of Physicians (FACP)
  • In Vino Vita Young Investigator Award for research on the genetic and clinical characterization of early- and late-onset renal cell carcinoma (Fox Chase Cancer Center)
  • Member, Trainee and Early Career Advisory Group (TECG), American Society of Clinical Oncology (ASCO), 2022 to 2025
  • Mentor, Medical Student/Resident Virtual Mentorship Program, American Society of Clinical Oncology (ASCO)
  • Abstract Achievement Award, American Society of Hematology (ASH)
  • Outstanding Teaching Award, Principles and Practice of Clinical Research, Harvard T.H. Chan School of Public Health (multiple years)
  • Reviewer of the Month, ACR AME Case Reports Journal
  • Resident Forum Abstract Award, American College of Physicians (ACP)
  • Trinity Health Research Day Award

Publications

1. Kaur, J., Hasler, J. S., Handorf, E. A., Zibelman, M. R., Anari, F., Geynisman, D. M., & Ghatalia, P.(2025). Comparison of outcomes between African American and European American patients with Metastatic Clear Cell Renal Cell Carcinoma receiving Immune Checkpoint Inhibitors. Clinical Genitourinary Cancer, 102304.

2. Kaur J, Vijayvergia N. Narrative Review of Immunotherapy in Gastroentero-Pancreatic Neuroendocrine Neoplasms. Current Oncology [Internet]. 2023; 30:8653–64. Available from:
http://dx.doi.org/10.3390/curroncol30090627

3. Kaur, J., Choi, W., Geynisman, DM., Plimack, ER., Ghatalia, P. Role of immunotherapy in localized muscle Invasive urothelial cancer. Ther Adv Med Oncol. 2021 Sep; 13: 17588359211045858

4. Kaur, J., Mir T., Gill, R., et al. Immunotherapeutic approach for advanced pancreatic adenocarcinoma.Immunotherapy. 2021 Jun;13(9):767-782.

5. Peshin S, Dharia A, Takrori E, Kaur J, Thanikachalam K, Iyer R. Understanding Chemotherapy-Induced Thrombocytopenia: Implications for Gastrointestinal Cancer Treatment. Current Oncology. 2025; 32(8):455. https://doi.org/10.3390/curroncol32080455

6. Kaur, J., Wookey, V., Meeker, C. R., Meghan Connors, M., Handorf, E. A., Tejani, M. A., & Dotan, E.(2025). Assessment of nutritional status in elderly patients with gastroesophageal cancer: A post hoc analysis. American Society of Clinical Oncology Gastrointestinal Cancer Symposium; 2025.